Lifesciences III L.P. Clarus SEC EDGAR Filings (CIK 0001597143)

SEC EDGAR filings, ownership reports, and insider transactions for Lifesciences III L.P. Clarus.

Business address
101 Main Street, Suite 1210, Cambridge, MA, 02142
Top holdings (ownership)
PRAX, IMGO, and TALS
State of incorporation
DE
Fiscal year end
14 December
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Lifesciences III L.P. Clarus has filed 46 SEC EDGAR filings since 06 Feb 2014

Latest Filings

Recent SEC filings for Lifesciences III L.P. Clarus including SC 13D/A, 4, SC 13D and more.

Form type Document Filing Description Filing date Reporting date File number(s)
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A SC 13D/A 12 Jan 2023
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 01 Apr 2022 30 Mar 2022 001-40604
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A SC 13D/A 01 Apr 2022
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A SC 13D/A 12 Jan 2022
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 30 Jul 2021
4 Open 4 document View SEC filing for 4 FORM 4 20 Jul 2021 20 Jul 2021 001-40604
3 Open 3 document View SEC filing for 3 FORM 3 15 Jul 2021 15 Jul 2021 001-40604
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 14 May 2021 12 May 2021 001-39620
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 14 May 2021 11 May 2021 001-40384
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 06 May 2021 06 May 2021 001-40384
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 22 Oct 2020 20 Oct 2020 001-39620
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 15 Oct 2020 15 Oct 2020 001-39620
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 01 Oct 2020 01 Oct 2020 001-37410
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 01 Oct 2020 29 Sep 2020 001-39538
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 25 Sep 2020 24 Sep 2020 001-39538
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 30 Jul 2020 28 Jul 2020 001-39402
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 23 Jul 2020 23 Jul 2020 001-39402
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 3 TO SCHEDULE 13D 09 Jul 2020
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D 01 May 2020
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 3 TO SCHEDULE 13D 06 Sep 2019
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 3 TO SCHEDULE 13D 06 Aug 2019
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D 23 May 2019
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 22 May 2019 20 May 2019 001-38537
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 11 Jan 2019
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 11 Jan 2019
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D 11 Jan 2019
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 11 Jan 2019
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 11 Jan 2019
SC 13D Open SC 13D document View SEC filing for SC 13D CLARUS LIFESCIENCES III, L.P. GRITSTONE ONCOLOGY, INC. -- SCHEDULE 13D 12 Oct 2018
SC 13D Open SC 13D document View SEC filing for SC 13D CLARUS LIFESCIENCES III, L.P. ENTASIS THERAPEUTICS HOLDINGS INC. -- SCHEDULE 13D 09 Oct 2018
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 02 Oct 2018 28 Sep 2018 001-38670
4 Open 4 document View SEC filing for 4 FORM 4 02 Oct 2018 28 Sep 2018 001-38663
3 Open 3 document View SEC filing for 3 FORM 3 27 Sep 2018 27 Sep 2018 001-38663
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 25 Sep 2018 25 Sep 2018 001-38670
SC 13D Open SC 13D document View SEC filing for SC 13D CLARUS LIFESCIENCES III, L.P. FORTY SEVEN, INC. -- SCHEDULE 13D 12 Jul 2018
SC 13D Open SC 13D document View SEC filing for SC 13D CLARUS LIFESCIENCES III, L.P. AVROBIO, INC. -- SCHEDULE 13D 05 Jul 2018
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 02 Jul 2018 02 Jul 2018 001-38554
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Jun 2018 27 Jun 2018 001-38554
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 25 Jun 2018 25 Jun 2018 001-38537
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 20 Jun 2018 20 Jun 2018 001-38537
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A SC 13D/A 19 Jun 2018
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A NEOTHETICS, INC. - AMENDMENT #1 09 Feb 2016
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 26 Jan 2016
SC 13G Open SC 13G document View SEC filing for SC 13G NEOTHETICS, INC. 13 Feb 2015
D/A Open D/A document View SEC filing for D/A 19 Jun 2014 021-211426
D Open D document View SEC filing for D 06 Feb 2014 021-211426

About this filer

Lifesciences III L.P. Clarus files with the SEC under CIK 0001597143. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages